Publish In |
International Journal of Advances in Science, Engineering and Technology(IJASEAT)-IJASEAT |
Journal Home Volume Issue |
||||||||
Issue |
Volume-9,Issue-3 ( Jul, 2021 ) | |||||||||
Paper Title |
Identification of Drug Targets for AKT-1 in Proteus Syndrome-In Silico Docking Studies | |||||||||
Author Name |
Reeya Tanwar, Asmita Das | |||||||||
Affilition |
Delhi Technological University, Bawana Rd, ShahbadDaulatpur, Rohini, Delhi -110042, India Assistant Professor, Delhi Technological University, Bawana Rd, ShahbadDaulatpur, Rohini, Delhi -110042, India | |||||||||
Pages |
34-38 | |||||||||
Abstract |
Proteus Syndrome is a rare disorder with an estimated prevalence of <1/1,000,000, this disorder is characterized by patchy or mosaic postnatal overgrowth of different body parts. Although the exact mechanism of proteus syndrome is not known but researchers have stated that a somatic mutation in AKT-1 results in such symptoms. Our study aims to identify the drug targets in AKT-1 protein that can further be used to look for potential drug candidates for this disease, in order to do this Miransertib; a drug that has shown therapeutic effect in a teenager suffering from proteus syndrome and ovarian carcinoma has been selected to study the different type of interactions that take place to ease the process of drug discovery. Keywords - Proteus Syndrome, Overgrowth, Miransertib, AKT-1 | |||||||||
View Paper |